Why Almonty Industries (ALM) stock slid Friday — and what matters before Monday

Why Almonty Industries (ALM) stock slid Friday — and what matters before Monday

Toronto, January 10, 2026, 21:22 (EST) — Market closed

Almonty Industries Inc’s shares on the U.S. market dropped 7.3% Friday, finishing at $8.63. The stock swung between $8.38 and $9.37, with roughly 3.7 million shares changing hands before bouncing back to $8.82 in after-hours trading. (StockAnalysis)

The move followed the expiration of a short lock-up tied to December financing, introducing new supply pressure on the stock. A lock-up prevents certain holders from selling shares for a defined period after a deal; S&P Capital IQ data cited by MarketScreener showed the restriction ran from Dec. 9 to Jan. 8, covering options, equity-linked instruments, and common shares. (MarketScreener)

The timing is key because the December deal stood out compared to Almonty’s usual trading volume. The company sold 20.7 million common shares at $6.25 each, pulling in $129.375 million before fees. BofA Securities led the underwriting. Almonty plans to channel the cash into multiple projects. CEO Lewis Black said the firm is “fully capitalized” to carry out its exploration and expansion plans. (Business Wire)

Almonty’s shares in Toronto slipped 6.8% to close at C$12.00 Friday, hitting a low of C$11.65 during the session. Trading volume reached roughly 714,000 shares. (StockAnalysis)

Commodity sentiment plays a role here, though Friday’s moves appeared mainly driven by stock-specific factors. Almonty’s website notes its tungsten pricing data comes from FastMarkets and gets updated every Friday. The company points out that tungsten pricing often refers to ammonium paratungstate (APT), a key chemical benchmark for the metal. (Almonty Industries)

The selling forced investors to weigh two opposing signals. Almonty’s recent financing provided fresh capital, yet lifting selling restrictions can still weigh on the stock if holders choose to cash out.

There’s a clear downside risk: if more stock hits the market than buyers can handle at current prices. Just a few days of steady selling could overwhelm a small, volatile miner.

Traders are eyeing ownership and insider disclosures that could surface after the lock-up expires, alongside block prints signaling major holders unloading. Volume will reveal the story.

Almonty positions itself as a tungsten supplier with both operating assets and development projects. Still, the market often revalues these companies fast whenever the funding environment changes. Securing cash doesn’t erase execution risk.

Markets in the U.S. and Canada reopen Monday, Jan. 12. Investors will watch closely to see if Friday’s sell-off spills over or eases after the weekend break.

Stock Market Today

  • Genting Singapore stock at S$0.73 as funds turn net sellers ahead of Feb 19 earnings
    January 11, 2026, 3:33 AM EST. Genting Singapore closed Friday at S$0.73, up 0.7%, but fund-flow data show institutions started 2026 as net sellers. The shares traded in a narrow range (S$0.725-S$0.735) with a 52-week span of S$0.66-S$0.80. Analysts are broadly positive: average target around S$0.878, implying roughly 20% upside. Investors await the Feb 19 earnings release for clues on revenue, margins, and the Resorts World Sentosa overhaul. Morgan Stanley flags debt funding as a viable option, with about S$5 billion still needed for the next expansion phase. A softer visitor spend or higher costs could squeeze cash returns as capital expenditure (capex) rises. Friday's close keeps the stock near the critical S$0.72 level, with a potential move toward the upper end of the year range if earnings surprise to the upside.
Merit Medical stock slides 7% after board shake-up and early Q4 revenue range — what to watch next
Previous Story

Merit Medical stock slides 7% after board shake-up and early Q4 revenue range — what to watch next

Wave Life Sciences stock drops 7% into JPM Healthcare Conference week — what to know next
Next Story

Wave Life Sciences stock drops 7% into JPM Healthcare Conference week — what to know next

Go toTop